Davis Heart and Lung Research Institute and Department of Internal Medicine, The Ohio State University College of Medicine, Columbus (A.N.C., S.K.M., M.F., Y.W., E.D.L.).
Nora Eccles Harrison Cardiovascular Research and Training Institute, University of Utah, Salt Lake City (C.H.S., S.G.D.).
Circulation. 2021 May 4;143(18):1797-1808. doi: 10.1161/CIRCULATIONAHA.120.052671. Epub 2021 Feb 19.
The failing heart is energy starved with impaired oxidation of long-chain fatty acids (LCFAs) at the level of reduced CPT1 (carnitine palmitoyltransferase 1) activity at the outer mitochondrial membrane. Recent work shows elevated ketone oxidation in failing hearts as an alternate carbon source for oxidative ATP generation. We hypothesized that another short-chain carbon source, short-chain fatty acids (SCFAs) that bypass carnitine palmitoyltransferase 1, could similarly support energy production in failing hearts.
Cardiac hypertrophy and dysfunction were induced in rats by transverse-aortic constriction (TAC). Fourteen weeks after TAC or sham operation, isolated hearts were perfused with either the 4 carbon, C-labeled ketone (D3-hydroxybutyrate) or the 4 carbon, C-labeled SCFA butyrate in the presence of glucose and the LCFA palmitate. Oxidation of ketone and SCFA was compared by in vitro C nuclear magnetic resonance spectroscopy, as was the capacity for short-chain carbon sources to compensate for impaired LCFA oxidation in the hypertrophic heart. Adaptive changes in enzyme expression and content for the distinct pathways of ketone and SCFA oxidation were examined in both failing rat and human hearts.
TAC produced pathological hypertrophy and increased the fractional contributions of ketone to acetyl coenzyme-A production in the tricarboxylic acid cycle (0.60±0.02 sham ketone versus 0.70±0.02 TAC ketone; <0.05). However, butyrate oxidation in failing hearts was 15% greater (0.803±0.020 TAC SCFA) than ketone oxidation. SCFA was also more readily oxidized than ketone in sham hearts by 15% (0.693±0.020 sham SCFA). Despite greater SFCA oxidation, TAC did not change short-chain acyl coenzyme-A dehydrogenase content. However, failing hearts of humans and the rat model both contain significant increases in acyl coenzyme-A synthetase medium-chain 3 enzyme gene expression and protein content. The increased oxidation of SCFA and ketones occurred at the expense of LCFA oxidation, with LCFA contributing less to acetyl coenzyme-A production in failing hearts perfused with SCFA (0.190±0.012 TAC SCFA versus 0.3163±0.0360 TAC ketone).
SCFAs are more readily oxidized than ketones in failing hearts, despite both bypassing reduced CPT1 activity and represent an unexplored carbon source for energy production in failing hearts.
衰竭心脏的能量供应不足,长链脂肪酸(LCFAs)的氧化受损,位于外线粒体膜的 CPT1(肉毒碱棕榈酰转移酶 1)活性降低。最近的研究表明,衰竭心脏中酮的氧化增加,作为氧化 ATP 生成的替代碳源。我们假设另一种短链碳源,绕过肉毒碱棕榈酰转移酶 1 的短链脂肪酸(SCFAs),也可以类似地为衰竭心脏提供能量。
通过横主动脉缩窄(TAC)在大鼠中诱导心脏肥大和功能障碍。TAC 或假手术后 14 周,用 4 碳、C 标记的酮(D3-羟丁酸)或 4 碳、C 标记的 SCFA 丁酸在葡萄糖和 LCFA 棕榈酸存在下灌流分离的心脏。通过体外 C 磁共振光谱比较酮和 SCFA 的氧化,比较两种短链碳源在肥大心脏中补偿 LCFA 氧化受损的能力。检查衰竭大鼠和人心肌中酮和 SCFA 氧化的不同途径的酶表达和含量的适应性变化。
TAC 产生病理性肥大,并增加了酮在三羧酸循环中产生乙酰辅酶 A 的分数贡献(0.60±0.02 假酮对 0.70±0.02 TAC 酮;<0.05)。然而,衰竭心脏中丁酸盐的氧化增加了 15%(0.803±0.020 TAC SCFA),高于酮的氧化。SCFA 在假心脏中的氧化也比酮容易增加 15%(0.693±0.020 假 SCFA)。尽管 SCFA 氧化增加,但 TAC 并未改变短链酰基辅酶 A 脱氢酶含量。然而,人和大鼠模型的衰竭心脏都显著增加了酰基辅酶 A 合成酶中链 3 酶基因表达和蛋白含量。SCFA 和酮的氧化增加是以 LCFA 氧化减少为代价的,用 SCFA 灌注的衰竭心脏中 LCFA 对乙酰辅酶 A 的产生贡献减少(0.190±0.012 TAC SCFA 对 0.3163±0.0360 TAC 酮)。
尽管 SCFA 绕过降低的 CPT1 活性,并且代表衰竭心脏中能量产生的未探索的碳源,但 SCFA 比酮更容易在衰竭心脏中氧化。